AN2 Therapeutics
lung disease a rare chronic and progressive infectious disease an therapeutics | AN2 Therapeutics
Company
Deck Type
Sector
Industry
Deck date
August 2022
Slide
8 of 25
Similar slides by AN2 Therapeutics
See diffirences between slides (animation)
IPO
March 2022
lung disease a rare chronic and progressive infectious disease is a group of species of commonly found in water and soil unlike tuberculosis not transmitted person to person is being developed for the most common type of complex mac mac causes of cases of lung disease this complex currently includes species most common are and chimaera symptoms similar to those associated with other chronic respiratory diseases cough sputum production fatigue causes chronic infection that progresses to fibrosis permanent lung damage and respiratory failure women and age group most affected year mortality rate between an therapeutics | AN2 Therapeutics
Other recent decks by AN2 Therapeutics
See all presentations (2 decks)
IPO
March 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io